Skip to main content
Access Resources

MJFF Publications

7181 - 7190 of 7540 Results
Title
Year
  • Year
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • RESTRICTED
    Title: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2
    Citation Count: 232
  • RESTRICTED
    Title: Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-011-0831-1
    Citation Count: 78
  • RESTRICTED
    Title: Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1242/jcs.079293
    Citation Count: 66
  • RESTRICTED
    Title: Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.11001
    Citation Count: 15
  • RESTRICTED
    Title: Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23737
    Citation Count: 36
  • RESTRICTED
    Title: Priorities in Parkinson's disease research
    Journal Name: Nature Reviews Drug Discovery
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/nrd3430
    Best OA location URL:
    Citation Count: 369
  • RESTRICTED
    Title: Biomarkers for Parkinson’s Disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488
    Best OA location URL:
    Citation Count: 36
  • RESTRICTED
    Title: Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23655
    Citation Count: 15
  • RESTRICTED
    Title: A Genome-Wide Linkage Screen in the Amish with Parkinson Disease Points to Chromosome 6
    Journal Name: Annals of Human Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/j.1469-1809.2011.00643.x
    Citation Count: 10
  • RESTRICTED
    Title: Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposure
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182152830
    Citation Count: 79
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.